Xiaolin Xue

641 total citations
34 papers, 425 citations indexed

About

Xiaolin Xue is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Xiaolin Xue has authored 34 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 7 papers in Complementary and alternative medicine. Recurrent topics in Xiaolin Xue's work include Cardiac electrophysiology and arrhythmias (11 papers), Ion channel regulation and function (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers). Xiaolin Xue is often cited by papers focused on Cardiac electrophysiology and arrhythmias (11 papers), Ion channel regulation and function (8 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers). Xiaolin Xue collaborates with scholars based in China, United States and Hong Kong. Xiaolin Xue's co-authors include Tianfang Wang, Gan‐Xin Yan, Albert Yeung, Qunhao Zhang, Lin Yang, Guoliang Li, Dan Han, Guizhi Liu, Donglin Guo and Marwan Badri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaolin Xue

34 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolin Xue China 13 230 208 74 44 37 34 425
Masamichi Yoshika Japan 10 181 0.8× 188 0.9× 16 0.2× 14 0.3× 31 0.8× 23 472
Kumiko Nagai Japan 9 116 0.5× 182 0.9× 12 0.2× 40 0.9× 62 1.7× 19 480
Jens Barthelmes Switzerland 10 220 1.0× 137 0.7× 24 0.3× 7 0.2× 22 0.6× 22 537
Gooitzen Alberts Netherlands 9 143 0.6× 122 0.6× 19 0.3× 9 0.2× 32 0.9× 11 407
Sachiko Honjo Japan 14 99 0.4× 69 0.3× 25 0.3× 12 0.3× 10 0.3× 40 480
Hatice Aygün Türkiye 12 54 0.2× 86 0.4× 16 0.2× 76 1.7× 86 2.3× 44 387
Joris H. De Maeyer Belgium 13 66 0.3× 159 0.8× 47 0.6× 24 0.5× 129 3.5× 24 787
Seung Kyum Kim United States 10 84 0.4× 64 0.3× 24 0.3× 18 0.4× 11 0.3× 25 344
Siwei Li China 12 34 0.1× 127 0.6× 37 0.5× 13 0.3× 21 0.6× 39 477
Pallab K. Ganguly Canada 17 286 1.2× 216 1.0× 14 0.2× 13 0.3× 39 1.1× 40 708

Countries citing papers authored by Xiaolin Xue

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Xue more than expected).

Fields of papers citing papers by Xiaolin Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Xue. The network helps show where Xiaolin Xue may publish in the future.

Co-authorship network of co-authors of Xiaolin Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Xue. A scholar is included among the top collaborators of Xiaolin Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Xue. Xiaolin Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Qianqian, Meihua Jin, Qiang Zhao, et al.. (2025). Natural products in traditional Chinese medicine for renal fibrosis: a comprehensive review. Frontiers in Pharmacology. 16. 1560567–1560567. 2 indexed citations
2.
3.
Chen, Jing, Chao Ye, Tieshan Wang, et al.. (2021). Study on the Effect of Macrophages on Vascular Endothelium in Mice With Different TCM Syndromes of Dyslipidemia and its Biological Basis Based on RNA-Seq Technology. Frontiers in Pharmacology. 12. 665635–665635. 5 indexed citations
4.
Zhang, Xinwei, Zhiyong Qian, Haipeng Tang, et al.. (2019). A new method to recommend left ventricular lead positions for improved CRT volumetric response and long-term prognosis. Journal of Nuclear Cardiology. 28(2). 672–684. 10 indexed citations
5.
Chen, Jing, Chao Ye, Xiaomin Hu, et al.. (2019). Serum metabolomics model and its metabolic characteristics in patients with different syndromes of dyslipidemia based on nuclear magnetic resonance. Journal of Pharmaceutical and Biomedical Analysis. 167. 100–113. 12 indexed citations
6.
Liu, Peng, et al.. (2019). Acquired long QT syndrome in chronic kidney disease patients. Renal Failure. 42(1). 54–65. 22 indexed citations
7.
Liu, Guizhi, Xiaolin Xue, Chuanyu Gao, et al.. (2017). Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation. Journal of the American Heart Association. 6(5). 6 indexed citations
8.
Li, Guoliang, et al.. (2016). Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy. Molecular Medicine Reports. 13(3). 2467–2475. 13 indexed citations
9.
Liao, Yan, Yin Lin, Cong Zhang, et al.. (2015). Intervention Effect of Baduanjin Exercise on the Fatigue State in People with Fatigue-Predominant Subhealth: A Cohort Study. The Journal of Alternative and Complementary Medicine. 21(9). 554–562. 24 indexed citations
10.
Li, Guoliang, et al.. (2015). GW26-e1798 Successful Treatment of a LQT8 Case with Mexiletine: 4 years of experience. Journal of the American College of Cardiology. 66(16). C176–C177. 1 indexed citations
11.
Badri, Marwan, Chinmay Patel, Guizhi Liu, et al.. (2015). Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures. JACC. Clinical electrophysiology. 1(4). 315–322. 50 indexed citations
12.
Xue, Xiaolin, et al.. (2015). Vasostatin-2 inhibits cell proliferation and adhesion in vascular smooth muscle cells, which are associated with the progression of atherosclerosis. Biochemical and Biophysical Research Communications. 469(4). 948–953. 12 indexed citations
13.
Wang, Tianfang, et al.. (2014). Intervention Effect of Baduanjin Exercise on the Fatigue State in People with Fatigue-Predominant Sub-Health: A Cohort Study. The Journal of Alternative and Complementary Medicine. 20(5). A68–A69. 1 indexed citations
14.
Zhao, Yan D., Xiaolin Xue, Hui Li, et al.. (2014). Distribution characteristics of Meridian Sinew (Jingjin) syndrome in 313 cases of whiplash-associated disorders. Chinese Journal of Integrative Medicine. 21(3). 234–240. 3 indexed citations
15.
Jia, Shaobin, Donglin Guo, Xiaolin Xue, et al.. (2010). Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKrblockade. British Journal of Pharmacology. 164(2). 308–316. 27 indexed citations
16.
Xue, Xiaolin. (2009). Construction of effectiveness evaluation system for traditional Chinese medicine interventions in subhealth. Journal of Chinese Integrative Medicine. 7(3). 201–204. 2 indexed citations
17.
Xue, Xiaolin, et al.. (2009). Fatigue self-assessment scale (FSAS).. 24(3). 348–349. 2 indexed citations
18.
Xue, Xiaolin, et al.. (2008). [Estimation on the reliability and validity of the fatigue self-assessment scale].. PubMed. 28(6). 550–4. 5 indexed citations
19.
Lian, Jiangfang, et al.. (2004). Clinical characteristics of 5 chinese LQTS families and phenotype-genotype correlation. Current Medical Science. 24(3). 208–211. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masamichi Yoshika Breakdown of academic impact, for papers by Kumiko Nagai Breakdown of academic impact, for papers by Jens Barthelmes Breakdown of academic impact, for papers by Gooitzen Alberts Breakdown of academic impact, for papers by Sachiko Honjo Breakdown of academic impact, for papers by Hatice Aygün Breakdown of academic impact, for papers by Joris H. De Maeyer Breakdown of academic impact, for papers by Seung Kyum Kim Breakdown of academic impact, for papers by Siwei Li Breakdown of academic impact, for papers by Pallab K. Ganguly
Rankless by CCL
2026